Covered recipient · General Payments record
PETER S KIM
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$14,876.50
- Reported across 338 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,360.00 | 1 |
| Travel and Lodging | $1,079.28 | 3 |
| Food and Beverage | $869.60 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $7,685.79 | 7 |
| ABBVIE INC. | $312.23 | 3 |
| Phathom Pharmaceuticals, Inc. | $141.76 | 1 |
| Celgene Corporation | $90.63 | 3 |
| QOL Medical, LLC | $31.93 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.93 | 1 |
| Lilly USA, LLC | $18.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $150.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074674 | CMS |
| ABBVIE INC. | $143.31 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074676 | CMS |
| ABBVIE INC. | $18.92 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104074678 | CMS |
| Celgene Corporation | $29.25 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101104252 | CMS |
| Celgene Corporation | $32.03 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101104256 | CMS |
| Celgene Corporation | $29.35 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101104280 | CMS |
| GENZYME CORPORATION | $162.06 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140009622 | CMS |
| GENZYME CORPORATION | $210.90 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1140009626 | CMS |
| GENZYME CORPORATION | $748.96 | 10/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1140009630 | CMS |
| GENZYME CORPORATION | $6,360.00 | 10/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140009634 | CMS |
| GENZYME CORPORATION | $24.84 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140009624 | CMS |
| GENZYME CORPORATION | $59.61 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140009628 | CMS |
| GENZYME CORPORATION | $119.42 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1140009632 | CMS |
| Lilly USA, LLC | $18.61 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135278579 | CMS |
| Phathom Pharmaceuticals, Inc. | $141.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151082057 | CMS |
| QOL Medical, LLC | $31.93 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147716117 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.93 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137602316 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.